• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

wBlogs

The World Blog Archived

  • Submit
  • Disclaimers
  • About
  • DMCA
  • Privacy Policy
  • Contact

You are here: Home / Enhancing Access to Genomic Medicine

Enhancing Access to Genomic Medicine

November 23, 2009 by www.technologyreview.com

Per Lofberg wants to bring genomic medicine to the masses by overcoming one of the field’s biggest barriers–getting insurers and other payers to cover the growing numbers of genetic tests reaching the market. To achieve that, he founded Generation Health, a health benefit management company that aims to sift through the data on these tests, which range from those that predict an individual’s risk of heart disease or cancer to those that determine how well a patient metabolizes a certain drug. Lofberg’s goal is to find the ones that provide the greatest medical utility and economic value. Earlier this month, the startup, based in Upper Saddle River, NJ, announced a partnership with CVS Caremark, which manages prescription benefits for about 50 million people. Generation Health will analyze 17 drugs that have accompanying diagnostic tests indicating how well the drug would work in an individual, including those for cancer, heart disease, and HIV, and determine which tests CVS should offer to its customers next year. “Now there is the opportunity to bring genetics to all the people CVS Caremark serves, and that is significant,” says Raju Kucherlapati, a geneticist at Harvard Medical School in Boston. A number of genetic tests can… Read full this story


  • The Mobile Healthcare (MHealth) Bible Market Research, Trends And Forecast To Grow Globally By 2020
  • Mobile Healthcare (MHealth) Bible Market will account for over 150 Million By 2020
  • Next Generation Cancer Diagnostics Market Size To 2022: Grand View Research, Inc.
  • Next Generation Cancer Diagnostics Market Size, Segmentation To 2022: Grand View Research, Inc.
Enhancing Access to Genomic Medicine have 266 words, post on www.technologyreview.com at November 23, 2009. This is cached page on wBlogs. If you want remove this page, please contact us.

Filed Under: Business Impact who roadmap on access to medicines and vaccines, npj genomic medicine, nhs genomic medicine service, npj genomic medicine impact factor, nature genomic medicine, genomic or personalized medicine, oxford genomic medicine centre, of genomic medicine, genomic medicine 2018, genomic medicine 2019, genomic medicine 2018 edinburgh, genomic medicine 2018 nijmegen, genomic medicine 2019 cambridge, genomic medicine whole exome, genomic medicine why, genomic cancer medicine program, genomic cancer precision medicine, for genomic medicine, genome medicine impact factor 2016, genome medicine impact factor 2015

Primary Sidebar

RSS Recent Stories

  • What’s the Difference Between a National Park and National Monument?
  • ‘One Small Step’ Act Encourages Protection of Human Heritage in Space
  • Capicola: The Italian Dried Meat Tony Soprano Called ‘Gabagool’
  • Is the Carolina Reaper the World’s Hottest Pepper?
  • 10 Signs That Streaming Movie Site Isn’t Legit

Sponsored Links

  • Nvidia GeForce RTX 3090 Listings show up on Amazon and Best Buy
  • Raspberry Pi Flashes Lights Based on Heartbeat in Real-time
  • AMD’s China-Exclusive Ryzen 5 3500X Listed At Newegg US
  • Best Prime Day soundbar deals 2020: What to expect
  • Raspberry Pi-Sized Iconikal Rockchip SBC Only $8 on Amazon
Copyright © 2021 wBlogs. Power by Wordpress.